These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23988303)

  • 1. Recurrent very late drug-eluting stent thrombosis.
    Duchini M; Fournier S; Iglesias JF; Roguelov C; Muller O; Eeckhout E
    Int J Cardiol; 2013 Oct; 168(4):e111-2. PubMed ID: 23988303
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).
    Waksman R; Kirtane AJ; Torguson R; Cohen DJ; Ryan T; Räber L; Applegate R; Waxman S; Gordon P; Kaneshige K; Leon MB;
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1093-102. PubMed ID: 25240540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very late thrombosis after subintimal sirolimus-eluting stent implantation during percutaneous coronary intervention for chronic total occlusion.
    Miyazaki S; Hiasa Y; Kishi K
    J Invasive Cardiol; 2010 Aug; 22(8):E162-5. PubMed ID: 20679685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple and recurrent coronary stent fractures.
    Alqarqaz M; Albashaireh D; Guerrero M
    J Invasive Cardiol; 2014 Jan; 26(1):E7-12. PubMed ID: 24402813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neointimal erosion resulting in very-late stent thrombosis.
    Mori H; Sone H; Takei Y; Tashiro K; Sasai M; Maeda A; Sato T; Suzuki H
    Coron Artery Dis; 2019 Jun; 30(4):312-313. PubMed ID: 30694821
    [No Abstract]   [Full Text] [Related]  

  • 6. Recurrent coronary stent thromboses and myocardial infarctions.
    Chen J; Rajeev A
    J Invasive Cardiol; 2007 Nov; 19(11):E350-4. PubMed ID: 17986737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
    Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of recurrent stent thrombosis in a drug-eluting stent following antiplateled therapy discontinuation].
    Wożakowska Kapłon B; Jaskulska Niedziela E; Niedziela J; Gutkowski W
    Kardiol Pol; 2011; 69(6):621-3; discussion 624. PubMed ID: 21678309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late stent thrombosis: can it be prevented?
    Mauri L; Galper BZ
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1103-4. PubMed ID: 25341706
    [No Abstract]   [Full Text] [Related]  

  • 10. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
    Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very late subacute thrombosis of a sirolimus-eluting stent after 57 months.
    Paturi A; Rothenberg M; Borzak S
    J Invasive Cardiol; 2009 Dec; 21(12):E252-3. PubMed ID: 19966378
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the efficacy and safety of paclitaxel-eluting coroflex please stents and paclitaxel-eluting stents in patients with coronary artery disease: a randomized PIPA trial.
    Kim HS; Park SJ; Park DW; Park SW; Cheong SS; Lee SG; Cho BR; Lee SW; Lee NH; Lee K;
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):799-806. PubMed ID: 22120995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial.
    Chen SL; Ye F; Zhang JJ; Zou JJ; Qian XS; Li F; Yang S; Ge Z; Shan SJ; Li XB; Xu T; Kan J; Lin L; Han YL
    Cardiovasc Ther; 2013 Aug; 31(4):193-200. PubMed ID: 22954234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-in-man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary lesions: clinical, Angiographic, and OCT outcomes of CREDIT-1.
    Wang G; Sun Z; Jin Q; Xu K; Li Y; Wang X; Ma Y; Liu H; Zhao X; Wang B; Deng J; Guan S; Ge M; Wang X; Xu B; Han Y
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():744-51. PubMed ID: 25630447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving management of patients treated by drug-eluting stent: prevention of late events.
    Niccoli G; Sgueglia GA; Montone RA; Roberto M; Banning AP; Crea F
    Cardiovasc Revasc Med; 2014 Mar; 15(2):100-8. PubMed ID: 24603193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial.
    Gao RL; Xu B; Lansky AJ; Yang YJ; Ma CS; Han YL; Chen SL; Li H; Zhang RY; Fu GS; Yuan ZY; Jiang H; Huo Y; Li W; Zhang YJ; Leon MB;
    EuroIntervention; 2013 May; 9(1):75-83. PubMed ID: 23685298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Prasugrel Therapy for Recurrent Left Main Stent Thrombosis in a Clopidogrel Hyporesponder.
    Kim YS; Lee SR
    Tex Heart Inst J; 2015 Oct; 42(5):483-6. PubMed ID: 26504448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late thrombosis after double versus single drug-eluting stent in the treatment of coronary bifurcations: a meta-analysis of randomized and observational Studies.
    Zimarino M; Corazzini A; Ricci F; Di Nicola M; De Caterina R
    JACC Cardiovasc Interv; 2013 Jul; 6(7):687-95. PubMed ID: 23769650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very late stent thrombosis in patients with first-generation drug-eluting stents: a systematic review of reported cases.
    Franck C; Eisenberg MJ; Dourian T; Grandi SM; Filion KB
    Int J Cardiol; 2014 Dec; 177(3):1056-8. PubMed ID: 25465837
    [No Abstract]   [Full Text] [Related]  

  • 20. Second-versus first-generation "Limus"-eluting stents in diabetic patients with coronary artery disease: a randomized comparison in setting of ISAR-TEST-4 trial.
    Kufner S; Byrne RA; Mehilli J; Massberg S; Birkmeier KA; Schulz S; Pache J; Schömig A; Kastrati A
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):E769-76. PubMed ID: 23754254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.